相关实验视频
Updated: May 11, 2025

08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.2K
静脉透析运动:在接受血液透析的患者中对动脉硬和步行速度的影响
Yu-Hsien Lai1,2, Chih-Hsien Wang1,2, Huei-Jhen Lin1
1Division of Nephrology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.
概括
在慢性血液透析患者中,日内有氧运动显著改善了动脉硬性和步行速度. 这项为期12个月的计划证明了没有不良事件的好处,增强了血管和身体健康.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心血管健康 心血管健康
- 运动生理学 运动生理学
背景情况:
- 慢性血液透析 (CHD) 患者面临着关于运动对血管和身体健康的争论.
- 动脉硬和运动障碍是心脏病的常见并发症.
- 对患者的结果来说,评估日内分析运动干预措施至关重要.
研究的目的:
- 评估一项日内有氧运动计划对心脏病患者的动脉硬 (心-大腿脉冲波速,cfPWV) 和身体功能 (步行速度,坐立测试) 的影响.
- 为了比较运动组和接受12个月定期护理的对照组之间的结果.
主要方法:
- 114名心血管疾病患者被随机分配到运动或对照组.
- 运动组进行了20分钟的低到中等强度自行车运动,每周3次,持续12个月.
- 带 - 骨脉冲波速度 (cfPWV) 和步行速度是主要的结果.
主要成果:
- 与对照组相比,在运动组观察到动脉刚度 (cfPWV) 的显著降低 (p<0.001).
- 运动组的步行速度明显更快 (p=0.019).
- 在5次坐立测试或身体组成中没有发现显著差异;没有报告的不良事件.
结论:
- 在慢性血液透析患者中,日内透析式自行车运动有效改善动脉硬性和步行速度.
- 12个月的干预表明了显著的血管和身体健康益处.
- 血液透析期间的有氧运动是心血管疾病患者的安全和有益的治疗策略.
相关概念视频
Exercise and Cardiac Output
702
Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be...
Sustained exercise increases the muscles' oxygen demand, which can be...
702
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
305
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
305

